Overview
Fluorine 18 labeled PSMA agents are PET radiotracers that target prostate specific membrane antigen to detect prostate cancer lesions with high sensitivity.
Properties
F18 label provides high resolution PET imaging and longer half life compared with some gallium agents enabling wider distribution and delayed imaging protocols.
Uses
Used for staging, restaging and localization of recurrent prostate cancer and for guiding targeted therapies and surgical planning.
Safety
Follow PET center protocols for patient preparation and radiation safety; be aware of physiologic uptake in salivary glands and kidneys.